Neuropro Spinal Jaxx recalls Spinal Jaxx Interbody Fusion Device, Model: 100001-511, Size: 9 H x 10 W x 25 L Product Usage: The Spinal Jaxx interbod…
- Recall date
- January 18, 2018
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-1350-2018
- FDA classification
- Class II
- Brand / firm
- Neuropro Spinal Jaxx
- Sold / distributed
- The devices were distributed in California.
Why it was recalled
The implant size is incorrectly etched on the implant. The size listed on the box is correct.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Spinal Jaxx Interbody Fusion Device, Model: 100001-511, Size: 9 H x 10 W x 25 L Product Usage: The Spinal Jaxx interbody fusion device is indicated for spinal fusion for patients with degenerative disc disease (DDD) at one or two contiguous levels of the lumbosacral spine (L2-S1). DDD is defined as discogenic back pain with degeneration of the disc confirmed by history and radiographic studies. Patients may also have up to Grade 1 spondylolisthesis or retrolisthesis at the involved level(s). The indicated patient population is skeletally mature patients who have had six (6) months of non-operative treatment. The Spinal Jaxx interbody fusion device must be used with autogenous bone graft material and with supplemental fixation.
Get recall alerts
Free email alert whenever Neuropro Spinal Jaxx has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Neuropro Spinal Jaxx